Literature DB >> 7786985

Evaluation of experiments with adaptive interim analyses.

P Bauer1, K Köhne.   

Abstract

A general method for statistical testing in experiments with an adaptive interim analysis is proposed. The method is based on the observed error probabilities from the disjoint subsamples before and after the interim analysis. Formally, an intersection of individual null hypotheses is tested by combining the two p-values into a global test statistic. Stopping rules for Fisher's product criterion in terms of critical limits for the p-value in the first subsample are introduced, including early stopping in the case of missing effects. The control of qualitative treatment-stage interactions is considered. A generalization to three stages is outlined. The loss of power when using the product criterion instead of the optimal classical test on the whole sample is calculated for the test of the mean of a normal distribution, depending on increasing proportions of the first subsample in relation to the total sample size. An upper bound on the loss of power due to early stopping is derived. A general example is presented and rules for assessing the sample size in the second stage of the trial are given. The problems of interpretation and precautions to be taken for applications are discussed. Finally, the sources of bias for estimation in such designs are described.

Mesh:

Year:  1994        PMID: 7786985

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  107 in total

1.  Prospective, randomised, double blind trial of prophylaxis with single dose of co-amoxiclav before percutaneous endoscopic gastrostomy.

Authors:  G Preclik; S Grüne; H G Leser; J Lebherz; W Heldwein; K Machka; A Holstege; W V Kern
Journal:  BMJ       Date:  1999-10-02

Review 2.  [Monitoring of clinical trials. Methodology, interim analyses, and end results].

Authors:  M Pritsch; K Unnebrink
Journal:  Med Klin (Munich)       Date:  1999-12-15

3.  The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.

Authors:  Munyaradzi Dimairo; Philip Pallmann; James Wason; Susan Todd; Thomas Jaki; Steven A Julious; Adrian P Mander; Christopher J Weir; Franz Koenig; Marc K Walton; Jon P Nicholl; Elizabeth Coates; Katie Biggs; Toshimitsu Hamasaki; Michael A Proschan; John A Scott; Yuki Ando; Daniel Hind; Douglas G Altman
Journal:  BMJ       Date:  2020-06-17

4.  Two-stage adaptive enrichment design for testing an active factor.

Authors:  A Adam Ding; Samuel S Wu; Natalie E Dean; Rachel S Zahigian
Journal:  J Biopharm Stat       Date:  2019-05-28       Impact factor: 1.051

5.  Flexible design for following up positive findings.

Authors:  Kai Yu; Nilanjan Chatterjee; William Wheeler; Qizhai Li; Sophia Wang; Nathaniel Rothman; Sholom Wacholder
Journal:  Am J Hum Genet       Date:  2007-08-03       Impact factor: 11.025

6.  Efficacy of a benzocaine lozenge in the treatment of uncomplicated sore throat.

Authors:  Sigrun Chrubasik; Beate Beime; Florella Magora
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-10-21       Impact factor: 2.503

Review 7.  Efficiency perspectives on adaptive designs in stroke clinical trials.

Authors:  Ken Cheung; Petra Kaufmann
Journal:  Stroke       Date:  2011-09-01       Impact factor: 7.914

8.  Erythropoietin treatment in chemotherapy-induced anemia in previously untreated advanced esophagogastric cancer patients.

Authors:  Thomas Thomaidis; Arndt Weinmann; Martin Sprinzl; Stephan Kanzler; Jochen Raedle; Matthias Ebert; Carl Cristoph Schimanski; Peter Robert Galle; Thomas Hoehler; Markus Moehler
Journal:  Int J Clin Oncol       Date:  2013-03-27       Impact factor: 3.402

Review 9.  A comparison of phase II study strategies.

Authors:  Sally Hunsberger; Yingdong Zhao; Richard Simon
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

10.  A randomized, controlled, prospective trial to evaluate the haemostatic effect of Lyostypt versus Surgicel in arterial bypass anastomosis: "COBBANA" trial.

Authors:  Petra Baumann; Hardy Schumacher; Johannes Hüsing; Steffen Luntz; Hanns-Peter Knaebel
Journal:  Trials       Date:  2009-09-29       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.